highperformr logo

Zosano Pharma's Overview

Total employees57
HeadquartersFremont
Founded2006

Zosano Pharma Corporation was a clinical-stage biopharmaceutical company that focused on developing and commercializing its proprietary transdermal microneedle patch system. This technology aimed to provide rapid systemic administration of drugs and biologics. Their lead product candidate, M207 (Qtrypta™), was a zolmitriptan-coated microneedle patch developed for the acute treatment of migraine. Despite promising technology, the company faced regulatory setbacks and filed for Chapter 11 bankruptcy in June 2022. Its key assets, including the microneedle technology platform, were acquired by EmergPharma Inc. in October 2022. The information presented here reflects Zosano Pharma's operational period as an independent entity.

Where is Zosano Pharma's Headquarters?

Zosano Pharma officeZosano Pharma officeZosano Pharma officeZosano Pharma office
*Images sourced via web search. Rights belong to original owners

HQ Function

Served as the central hub for all corporate functions, including research and development, clinical trial operations, manufacturing process development, and administrative activities.

Notable Features:

The facility likely housed specialized laboratories for microneedle patch development, small-scale GMP manufacturing capabilities for clinical trial materials, quality control labs, and R&D labs for formulation and device engineering.

Work Culture:

As a clinical-stage biopharmaceutical company, Zosano Pharma likely fostered a science-driven, innovative, and results-oriented work culture. Employees were focused on advancing pipeline candidates through clinical development and navigating the regulatory landscape.

HQ Significance:

This headquarters was pivotal for the innovation and development of Zosano's proprietary microneedle patch technology, particularly its lead candidate M207 for migraine treatment. All strategic decisions and core research originated from this site.

Values Reflected in HQ: The headquarters represented Zosano's commitment to advancing drug delivery through innovative technology, scientific excellence in its research endeavors, and a focus on addressing unmet patient needs, particularly in the area of acute migraine management.

Location:

Zosano Pharma's operations were primarily concentrated in the United States, with its headquarters in Fremont, California, serving as the main center for R&D and corporate functions. While its product candidates, if approved, would have targeted global markets, the company did not have a significant physical international office presence. Its global strategy would have likely involved partnerships for international commercialization.

Street Address:

34790 Ardentech Court

City:

Fremont

State/Province:

California

Country:

USA

Zosano Pharma's Global Presence

Buying Intent Signals for Zosano Pharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Zosano Pharma

As of April 2025, Zosano Pharma' leadership includes:

Steven Lo - President, Chief Executive Officer, and Director
Christine Matthews - Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer
Donald J. Kellerman, Pharm.D. - Vice President, Clinical Development and Medical Affairs

Investors of Zosano Pharma

Zosano Pharma has been backed by several prominent investors over the years, including:

New Enterprise Associates (NEA) (Early Stage Investor)
ProQuest Investments (Early Stage Investor)
Publicly Traded on NASDAQ (Ticker: ZSAN) with various institutional and retail investors prior to delisting.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In the 12-18 months leading up to its June 2022 bankruptcy filing and subsequent asset sale in October 2022, Zosano Pharma made a key commercial executive hire. The core leadership team largely remained in place through the bankruptcy proceedings, after which their roles with the Zosano Pharma entity concluded.

Departures

Steven Lo, Leadership role with Zosano Pharma concluded following the company's Chapter 11 bankruptcy and subsequent asset sale.
Christine Matthews, Leadership role with Zosano Pharma concluded following the company's Chapter 11 bankruptcy and subsequent asset sale.
Donald J. Kellerman, Leadership role with Zosano Pharma concluded following the company's Chapter 11 bankruptcy and subsequent asset sale.

New Appointments:

Hayley Lewis, Appointed to establish and lead Zosano's commercialization efforts for its product candidates.

Technology (Tech Stack) used by Zosano Pharma

Discover the tools Zosano Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Zosano Pharma Email Formats and Examples

While Zosano Pharma is no longer operating independently, its email format likely followed common corporate structures. Typical formats for pharmaceutical companies include first initial followed by last name, or first name separated by a dot from the last name.

flast@zosanopharma.com (e.g., jsmith@zosanopharma.com) or first.last@zosanopharma.com (e.g., john.smith@zosanopharma.com)

Format

sdoe@zosanopharma.com

Example

0 (Company's independent operations ceased in 2022; emails are inactive)%

Success rate

News and media

PR NewswireOctober 7, 2022

Zosano Pharma assets acquired by EmergPharma Inc.

EmergPharma Inc. announced its acquisition of the assets of Zosano Pharma Corporation, including its microneedle drug delivery system and related intellectual property, following Zosano's Chapter 11 bankruptcy. EmergPharma intends to continue the development of the microneedle patch technology....more

BioSpaceJune 15, 2022

Zosano Pharma Files for Chapter 11 Bankruptcy Protection

Zosano Pharma Corporation filed for voluntary Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware. The company aimed to pursue a sale of its assets, citing ongoing financial constraints and regulatory setbacks....more

FierceBiotechApril 21, 2020

Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta (M207) NDA

Zosano Pharma announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for Qtrypta™ (M207), its microneedle patch for acute migraine treatment. The CRL cited issues related to inconsistent drug exposure levels observed in studies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Zosano Pharma, are just a search away.